Interventional cardiology – what’s new after meetings in Barcelona and San Francisco? Meeting Proceedings
Article Sidebar
Published:
Dec 31, 2009
Keywords:
fractional flow reserve, risk score, prasugrel, clopidogrel, proton pump inhibitor
Main Article Content
Abstract
The two largest global medical and scientific symposiums dedicated to interventional cardiovascular medicine are PCR in Barcelona and TCT in San Francisco. In 2009 a lot of new clinical data and trials were presented during these meetings. In this article authors focused on the trials the most relevant to the clinical practice. The results of FAME, PLATO, CURRENT STEMI PCI, COGENT trials, subanalysis of TRITON-TIMI 38 trial and SYNTAX score were discussed.
Article Details
How to Cite
Janiszewski , M., & Wrzosek , K. (2009). Interventional cardiology – what’s new after meetings in Barcelona and San Francisco?. Medycyna Faktow (J EBM), 2(4(5), 84-88. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2637
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Kappetein P.: Two-year results of the SYNTAX trial presented at the European Society of Cardiology Meeting, Barcelona on September 2nd, 2009.
2. Tonino P.A.L., De Bruyne B., Pijls N.H. et al.: Fractional flow reserve versus angiography for guiding percutaneous coronary angiography. N. Engl. J. Med. 2009; 360: 213-224.
3. Wallentin L., Becker R.C., Budaj A.: Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N. Eng. J. Med. 2009, 361: 1045-1057.
4. Cohen J.D.: TRITON TIMI 38 – economic substudy – presented at: Transcatheter Cardiovascular Therapeutics; Sept. 21–15, 2009; San Francisco.
5. Mehta S.: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent Events/Optimal Antiplatelet Strategy for Interventions – PCI substudy – presented at: Transcatheter Cardiovascular Therapeutics, Sept. 21–15, 2009; San Francisco.
6. Bhatt D.: COGENT: A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel presented at: Transcatheter Cardiovascular Therapeutics; Sept. 21–15, 2009; San Francisco.
2. Tonino P.A.L., De Bruyne B., Pijls N.H. et al.: Fractional flow reserve versus angiography for guiding percutaneous coronary angiography. N. Engl. J. Med. 2009; 360: 213-224.
3. Wallentin L., Becker R.C., Budaj A.: Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N. Eng. J. Med. 2009, 361: 1045-1057.
4. Cohen J.D.: TRITON TIMI 38 – economic substudy – presented at: Transcatheter Cardiovascular Therapeutics; Sept. 21–15, 2009; San Francisco.
5. Mehta S.: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent Events/Optimal Antiplatelet Strategy for Interventions – PCI substudy – presented at: Transcatheter Cardiovascular Therapeutics, Sept. 21–15, 2009; San Francisco.
6. Bhatt D.: COGENT: A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel presented at: Transcatheter Cardiovascular Therapeutics; Sept. 21–15, 2009; San Francisco.